Dopamine Agonists: all 968 studies that test it
Page 8 of 10. Open to participants first (53), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Pramipexole Extended Release in the Treatment of Essential TremorWithdrawnNCT01441284Phase 3
- Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)CompletedNCT01437293Phase 1
- Ropinirole PR Pharmacokinetics Study Among Chinese Healthy SubjectsCompletedNCT01435915Phase 1
- Aripiprazole for the Augmentation of Antidepressant TherapyCompletedNCT01429831Phase 4
- A PET Study in Healthy VolunteersCompletedNCT01424449Phase 1
- Dexpramipexole Renal PK StudyCompletedNCT01424176Phase 1
- Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer SurgeryCompletedNCT01418118Phase 4
- Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk PrediabeticsCompletedNCT01411930Phase 4
- Effect of Cabergoline on Weight and Glucose ToleranceCompletedNCT01395602Phase 1/2
- Aripiprazole and Resistant Postpartum DepressionCompletedNCT01386086Phase 3
- Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape)Status unknownNCT01361425Phase 4
- Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled StudyStatus unknownNCT01361373Phase 4
- Study to Compare Adhesiveness of Two Different Rotigotine Patch FormulationsCompletedNCT01338896Phase 1
- Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy VolunteersCompletedNCT01327261Phase 4
- Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt DietCompletedNCT01324245Not applicable
- Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With FibromyalgiaCompletedNCT01323374Phase 2
- Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective DisorderStatus unknownNCT01320982Phase 3
- Comparing Different Levodopa/Carbidopa/Entacapone Treatment RegimensCompletedNCT01296464Phase 2
- Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease PatientsCompletedNCT01291537Phase 2
- Dopaminergic Modulation of Cognition and Psychomotor FunctionCompletedNCT01218425Not applicable
- A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease SubjectsCompletedNCT01171313Phase 2
- Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in SchizophreniaCompletedNCT01164059Phase 4
- Effects of Aripiprazole and Haloperidol on Mesolimbic System FunctioningCompletedNCT01161277Phase 4
- Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)CompletedNCT01154829Not applicable
- Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.Status unknownNCT01143584Not applicable
- Tolerance and Effect of Antipsychotics in Children and Adolescents With PsychosisCompletedNCT01119014Phase 4
- Pramipexole for Binge Eating DisorderWithdrawnNCT01106053Phase 3
- Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced DyskinesiaCompletedNCT01092065Phase 2
- Aripiprazole and Prolactin StudyCompletedNCT01085383Phase 4
- ARIpiprazole in Anorexia NErvosaStatus unknownNCT01082848Phase 3
- Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in SchizophreniaCompletedNCT01066403Not applicable
- Extended Long-Term Safety Study of KW-6500CompletedNCT01063621Phase 3
- Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500CompletedNCT01058291Phase 3
- Standard Comprehensive Intervention to Treat First-episode SchizophreniaStatus unknownNCT01057849Not applicable
- Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of SchizophreniaCompletedNCT01052389Phase 4
- Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and QuetiapineStatus unknownNCT01047215Phase 4
- Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) StudyCompletedNCT01044992Not applicable
- Efficacy and Safety of Aripiprazole in First Episode PsychosisCompletedNCT01026584Phase 4
- A Study to Assess the Effect of Safinamide on Levodopa PharmacokineticsCompletedNCT01026428Phase 1/2
- Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease PatientsCompletedNCT01023282Phase 1
- Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) ProgramCompletedNCT01009567Phase 1/2
- Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine AgonistsCompletedNCT01007864Phase 3
- Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum CardiomyopathyCompletedNCT00998556Phase 2
- Impact of Uterotonic Agents on Isolated Human MyometriumCompletedNCT00989027Not applicable
- Fenoldopam in Pediatric Cardiac SurgeryCompletedNCT00982527Phase 3
- Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic SyndromeCompletedNCT00956189Not applicable
- Long-Term Safety Study of KW-6500 in Patients With Parkinson's DiseaseCompletedNCT00955318Phase 3
- Effect of Dopaminergic Medication on Recovery of AphasiaCompletedNCT00941265Not applicable
- An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease SubjectsCompletedNCT00914602Phase 1/2
- Duodenal Levodopa Infusion, Quality of Life and Autonomic Nervous System in Parkinson's DiseaseCompletedNCT00914134Phase 4
- Metabolic Effects of Antipsychotic Substitution in ChildrenWithdrawnNCT00910780Phase 2/3
- Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) InhibitorsCompletedNCT00906828Phase 4
- A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.TerminatedNCT00903838Phase 2
- Bipolar Study of Seroquel XR With Pramipexole DihydrochlorideCompletedNCT00893841Phase 2
- Study of Cabergoline in Treatment of Corticotroph Pituitary TumorCompletedNCT00889525Phase 3
- Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa PharmacokineticsCompletedNCT00888186Phase 4
- Aripiprazole and Topiramate on Free-Choice Alcohol UseCompletedNCT00884884Phase 2/3
- Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major DepressionCompletedNCT00873795Not applicable
- Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar DisordersCompletedNCT00845988Phase 4
- Aripiprazole for Neuroleptic-Induced Tardive DyskinesiaStatus unknownNCT00837707Phase 4
- Effect of Levodopa on Human Multifocal ElectroretinogramCompletedNCT00812760Phase 4
- Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712CompletedNCT00805454Phase 1
- Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain InjurySuspendedNCT00761228Phase 2
- Comparison of Continuous and Pulsatile Apomorphine in Parkinson's DiseaseWithdrawnNCT00758368Phase 2
- The Pathophysiology of Orthostatic HypotensionCompletedNCT00748059Phase 1
- Fenoldopam and Splanchnic Perfusion During Cardiopulmonary BypassCompletedNCT00747331Phase 4
- A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine DependenceStatus unknownNCT00737256Phase 2
- Aripiprazole for Methamphetamine Dependence: Double Blind Placebo TrialWithdrawnNCT00728312Phase 4
- Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute SchizophreniaCompletedNCT00712686Phase 3
- Pharmacokinetic Study With Repeated Doses of StalevoCompletedNCT00693862Phase 1
- Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy SubjectsCompletedNCT00689559Phase 1
- A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed ConditionsCompletedNCT00674310Not applicable
- A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted ConditionsCompletedNCT00673088Not applicable
- Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's DiseaseCompletedNCT00666653Phase 1
- Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation SyndromeCompletedNCT00665041Phase 2
- Dopamine Agonist for Hemispatial Neglect and Motor Deficit Post StrokeCompletedNCT00663338Phase 2
- Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting ConditionsCompletedNCT00653055Phase 1
- Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed ConditionsCompletedNCT00652873Phase 1
- Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg TypeStatus unknownNCT00639119Phase 2
- Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)CompletedNCT00634556Phase 1
- A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized PatientsCompletedNCT00634348Phase 4
- A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLSCompletedNCT00627003Phase 3
- The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs SyndromeCompletedNCT00626418Phase 2
- A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLSCompletedNCT00625547Phase 3
- The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's DiseaseCompletedNCT00623324Phase 2
- Fenoldopam and Acute Renal FailureCompletedNCT00621790Phase 3
- Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa TherapyCompletedNCT00610103Phase 2
- Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing OffWithdrawnNCT00601978Phase 4
- Effect of Gene Variants on Dopamine Receptor Natriuretic ResponsesStatus unknownNCT00592150Phase 1
- Tinnitus Treatment With Piribedil Guided by Acoustic Otoemissions and ElectrocochleographyCompletedNCT00591994Not applicable
- Remediation of Schizophrenia Sensory Gating Deficit With AripiprazoleStatus unknownNCT00567099Not applicable
- PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride BindingTerminatedNCT00562198Phase 2
- Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's DiseaseCompletedNCT00558337Phase 2
- Fenoldopam and Ketanserin for Acute Kidney Failure Prevention After Cardiac SurgeryTerminatedNCT00557219Phase 3
- Abilify in Bipolar Disorder for 24 Weeks Treatment EffectivenessCompletedNCT00545675Phase 4
- Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic AgentsCompletedNCT00545467Phase 4
- Abilify in Bipolar Disorder for 6 Weeks Treatment EffectivenessCompletedNCT00545142Phase 4
- Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and DyslipidemiaStatus unknownNCT00541554Phase 4
- Apomorphine Effect on Nociceptive Perception in Parkinson's: a Clinical and Imaging StudyCompletedNCT00524914Not applicable
- Health Evaluation of Abilify Long-term TherapyCompletedNCT00520650Phase 4